Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Glioma 2Glioblastoma 2Breast Neoplasms 2Brain Neoplasms 2Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Meningioma 1Medulloblastoma 1Lymphoma 1Hot Flashes 1Gliosarcoma 1Female Reproductive Cancer 1Fallopian Tube Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Astrocytoma 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Mind-Body Therapies × Clear all
NCT02166983 2014-11-24

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Stanford University

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT00711529 2013-06-24

Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.

Women and Infants Hospital of Rhode Island

Phase 3 Completed
27 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡